Efficacy of apraclonidine eye drops in treating ptosis secondary to myasthenia gravis: A pilot clinical trial.

Agha, Mohamad; Ismail, Helen; Sawaya, Raja; Salameh, Johnny

Agha, Mohamad; Ismail, Helen; Sawaya, Raja; Salameh, Johnny.

Afiliación

Agha M; Department of Neurology, American University of Beirut Medical Center, Beirut, Lebanon.
Ismail H; Department of Neurology, American University of Beirut Medical Center, Beirut, Lebanon.
Sawaya R; Department of Neurology, American University of Beirut Medical Center, Beirut, Lebanon.
Salameh J; Department of Neurology, American University of Beirut Medical Center, Beirut, Lebanon.

Muscle Nerve ; 68(2): 206-210, 2023 08.

Article en En | MEDLINE | ID: mdl-37259693

Asunto(s)

Blefaroptosis; Miastenia Gravis; Humanos; Blefaroptosis/etiología; Blefaroptosis/complicaciones; Clonidina/uso terapéutico; Miastenia Gravis/complicaciones; Miastenia Gravis/tratamiento farmacológico; Soluciones Oftálmicas/uso terapéutico; Estudios Retrospectivos

Palabras clave

apraclonidine; myasthenia gravis; ocular myasthenia gravis; ptosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Blefaroptosis / Miastenia Gravis Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google